Persistent swollen neck glands could be suspicious for cancer
the ONA take:
Patients with persistent unexplained swollen neck glands should be referred for specialist investigations, according to two reports from University of Exeter Medical School, in the United Kingdom. Such referrals could save thousands of death each year from lymphoma.
Latest available figures from 1995 to 1999 show that more than 6,320 deaths were avoidable during that period. In addition, more than 40% of patients had visited their GP with symptoms three or more times before being referred for cancer investigations.
Both reports used data from UK primary care patient records from the Clinical Practice Research Datalink (CPRD), focusing on patients older than 40 years.
The two reports produced similar results. The researchers conclude that the risk that persistent swollen glands are indicative of cancer is higher than previously thought, and primary care providers should consider referring these patients to a specialist earlier.
Patients with persistent unexplained swollen neck glands should be referred for specialist investigations.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|